StockData
Cryo-Cell International Inc logo

Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 3/30
$4.17−0.46 (-9.94%)

Close on Nov 18, 2026Market cap $33.62MP/E –Yield –

Cryo-Cell International gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Cryo-Cell International's gross profit for the twelve months ending Aug 31, 2026 was $24.45M, down 0.1% year over year. For fiscal 2025 it was $24.19M, up 0.6% from the year before. Over ten years it grew 4.6% a year on average. The highest annual figure on record is $24.19M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Nov 30, 2025$24.19M+0.6%
FY2024Nov 30, 2024$24.04M+4.7%
FY2023Nov 30, 2023$22.95M+6.5%
FY2022Nov 30, 2022$21.54M+8.3%
FY2021Nov 30, 2021$19.90M-7.4%
FY2020Nov 30, 2020$21.49M-1.3%
FY2019Nov 30, 2019$21.78M+5.3%
FY2018Nov 30, 2018$20.68M+10.8%
FY2017Nov 30, 2017$18.66M+7.5%
FY2016Nov 30, 2016$17.35M+12.2%
FY2015Nov 30, 2015$15.46M+6.7%
FY2014Nov 30, 2014$14.49M+6.0%
FY2013Nov 30, 2013$13.67M+4.5%
FY2012Nov 30, 2012$13.08M-3.2%
FY2011Nov 30, 2011$13.52M+2.0%
FY2010Nov 30, 2010$13.26M–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Aug 31, 2026$6.21M+3.1%
Q2 FY2026CQ2 2026May 31, 2026$6.10M+0.4%
Q1 FY2026CQ1 2026Feb 28, 2026$6.03M+0.7%
Q4 FY2025CQ4 2025Nov 30, 2025$6.11M-4.4%
Q3 FY2025CQ3 2025Aug 31, 2025$6.02M+1.4%
Q2 FY2025CQ2 2025May 31, 2025$6.07M+0.9%
Q1 FY2025CQ1 2025Feb 28, 2025$5.98M+3.4%
Q4 FY2024CQ4 2024Nov 30, 2024$6.39M+9.1%
Q3 FY2024CQ3 2024Aug 31, 2024$5.94M+4.0%
Q2 FY2024CQ2 2024May 31, 2024$6.02M+6.9%
Q1 FY2024CQ1 2024Feb 29, 2024$5.79M+0.5%
Q4 FY2023CQ4 2023Nov 30, 2023$5.85M+4.0%
Q3 FY2023CQ3 2023Aug 31, 2023$5.71M+7.2%
Q2 FY2023CQ2 2023May 31, 2023$5.63M+3.6%
Q1 FY2023CQ1 2023Feb 28, 2023$5.76M+11.7%
Q4 FY2022CQ4 2022Nov 30, 2022$5.63M+12.1%
Q3 FY2022CQ3 2022Aug 31, 2022$5.33M+5.7%
Q2 FY2022CQ2 2022May 31, 2022$5.43M+9.0%
Q1 FY2022CQ1 2022Feb 28, 2022$5.16M+6.3%
Q4 FY2021CQ4 2021Nov 30, 2021$5.02M-4.0%
Q3 FY2021CQ3 2021Aug 31, 2021$5.04M-12.3%
Q2 FY2021CQ2 2021May 31, 2021$4.98M-7.6%
Q1 FY2021CQ1 2021Feb 28, 2021$4.85M-5.3%
Q4 FY2020CQ4 2020Nov 30, 2020$5.23M-7.0%
Q3 FY2020CQ3 2020Aug 31, 2020$5.75M+2.1%
Q2 FY2020CQ2 2020May 31, 2020$5.39M-2.0%
Q1 FY2020CQ1 2020Feb 29, 2020$5.12M+1.8%
Q4 FY2019CQ4 2019Nov 30, 2019$5.62M-5.1%
Q3 FY2019CQ3 2019Aug 31, 2019$5.63M+4.6%
Q2 FY2019CQ2 2019May 31, 2019$5.50M+15.8%
Q1 FY2019CQ1 2019Feb 28, 2019$5.03M+8.7%
Q4 FY2018CQ4 2018Nov 30, 2018$5.92M+22.4%
Q3 FY2018CQ3 2018Aug 31, 2018$5.39M+9.5%
Q2 FY2018CQ2 2018May 31, 2018$4.75M+2.2%
Q1 FY2018CQ1 2018Feb 28, 2018$4.63M+8.6%
Q4 FY2017CQ4 2017Nov 30, 2017$4.84M+9.2%
Q3 FY2017CQ3 2017Aug 31, 2017$4.92M–
Q2 FY2017CQ2 2017May 31, 2017$4.64M–
Q1 FY2017CQ1 2017Feb 28, 2017$4.26M–
Q4 FY2016CQ4 2016Nov 30, 2016$4.43M–

More Cryo-Cell International figures

See a number that looks wrong?